Transverse myelitis as a first event of multiple sclerosis precipitated by Pfizer-BioNTech COVID-19 vaccination

BACKGROUND: Neurological complications from COVID-19 vaccines are rare CASE REPORT: Herein, we present the case of a previously healthy woman who developed incomplete transverse myelitis (TM) immediately after receiving her first injection of the Pfizer-BioNTech COVID-19 vaccine. CONCLUSION: This ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Guarnaccia, J, Creed, M, Muriel, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813198/
http://dx.doi.org/10.1016/j.nerep.2022.100074
_version_ 1784644795785805824
author Guarnaccia, J
Creed, M
Muriel, S
author_facet Guarnaccia, J
Creed, M
Muriel, S
author_sort Guarnaccia, J
collection PubMed
description BACKGROUND: Neurological complications from COVID-19 vaccines are rare CASE REPORT: Herein, we present the case of a previously healthy woman who developed incomplete transverse myelitis (TM) immediately after receiving her first injection of the Pfizer-BioNTech COVID-19 vaccine. CONCLUSION: This case is an example of TM as a first clinical event in the diagnosis of multiple sclerosis triggered by COVID-19 vaccination. A review of the FDA's Vaccine Adverse Event Reporting System (VAERS) reveals similar instances of TM. Clinicians should be aware of this potential complication from COVID-19 vaccination.
format Online
Article
Text
id pubmed-8813198
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Authors. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-88131982022-02-04 Transverse myelitis as a first event of multiple sclerosis precipitated by Pfizer-BioNTech COVID-19 vaccination Guarnaccia, J Creed, M Muriel, S Neuroimmunology Reports Article BACKGROUND: Neurological complications from COVID-19 vaccines are rare CASE REPORT: Herein, we present the case of a previously healthy woman who developed incomplete transverse myelitis (TM) immediately after receiving her first injection of the Pfizer-BioNTech COVID-19 vaccine. CONCLUSION: This case is an example of TM as a first clinical event in the diagnosis of multiple sclerosis triggered by COVID-19 vaccination. A review of the FDA's Vaccine Adverse Event Reporting System (VAERS) reveals similar instances of TM. Clinicians should be aware of this potential complication from COVID-19 vaccination. The Authors. Published by Elsevier B.V. 2022 2022-02-04 /pmc/articles/PMC8813198/ http://dx.doi.org/10.1016/j.nerep.2022.100074 Text en © 2022 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Guarnaccia, J
Creed, M
Muriel, S
Transverse myelitis as a first event of multiple sclerosis precipitated by Pfizer-BioNTech COVID-19 vaccination
title Transverse myelitis as a first event of multiple sclerosis precipitated by Pfizer-BioNTech COVID-19 vaccination
title_full Transverse myelitis as a first event of multiple sclerosis precipitated by Pfizer-BioNTech COVID-19 vaccination
title_fullStr Transverse myelitis as a first event of multiple sclerosis precipitated by Pfizer-BioNTech COVID-19 vaccination
title_full_unstemmed Transverse myelitis as a first event of multiple sclerosis precipitated by Pfizer-BioNTech COVID-19 vaccination
title_short Transverse myelitis as a first event of multiple sclerosis precipitated by Pfizer-BioNTech COVID-19 vaccination
title_sort transverse myelitis as a first event of multiple sclerosis precipitated by pfizer-biontech covid-19 vaccination
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813198/
http://dx.doi.org/10.1016/j.nerep.2022.100074
work_keys_str_mv AT guarnacciaj transversemyelitisasafirsteventofmultiplesclerosisprecipitatedbypfizerbiontechcovid19vaccination
AT creedm transversemyelitisasafirsteventofmultiplesclerosisprecipitatedbypfizerbiontechcovid19vaccination
AT muriels transversemyelitisasafirsteventofmultiplesclerosisprecipitatedbypfizerbiontechcovid19vaccination

Ejemplares similares